Novel approach for low‐dose pulmonary delivery of hydroxychloroquine in COVID‐19
Genre
Pre-printDate
2020-06-19Department
Pharmaceutical SciencesPermanent link to this record
http://hdl.handle.net/20.500.12613/252
Metadata
Show full item recordDOI
https://doi.org/10.1111/bph.15167Citation
Fassihi, S.C., Nabar, N.R. and Fassihi, R. (2020), Novel approach for low‐dose pulmonary delivery of hydroxychloroquine in COVID‐19. Br J Pharmacol. doi:10.1111/bph.15167Citation to related work
WileyThis is the pre-peer reviewed version of the following article: Fassihi, S.C., Nabar, N.R. and Fassihi, R. (2020), Novel approach for low‐dose pulmonary delivery of hydroxychloroquine in COVID‐19. Br J Pharmacol. doi:10.1111/bph.15167, which has been published in final form at https://doi.org/10.1111/bph.15167. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions
Has part
British Journal of PharmacologyADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.eduae974a485f413a2113503eed53cd6c53
http://dx.doi.org/10.34944/dspace/236